Anticancer agent 158
Product Specifications
Target
Others, EGFR
Related Pathways
JAK/STAT signaling, Others, Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
Anticancer agent 158 (compound 7c) demonstrates potent efficacy against various cancer cell lines, with IC50 values of 7.93 μM for HepG-2, 9.28 μM for MDA-MB-231, and 13.28 μM for HCT-116; however, it exhibits reduced potency with an IC50 of 181.89 μM against an unspecified cell line [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
